Financial TimesBiotechs face cash crunch after stock market ‘bloodbath’ by TheCompaniesFebruary 10, 20220 Share0 Facebook Twitter Google+ Pinterest Amazon reddit LinkedIn Myspace Struggle to raise fresh funds as ‘tourist’ investors lured by Covid successes dump shares
